epigallocatechin gallate has been researched along with Acute Promyelocytic Leukemia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, YJ; Fang, W; Huang, HP; Huang, P; Peng, ZL; Wang, DL | 1 |
| Della Via, FI; Ferro, KP; Franchi Junior, GC; Rego, EM; Saad, STO; Salazar-Terreros, MJ; Santos, I; Shiraishi, RN; Torello, CO | 1 |
| Borutinskaitė, V; Gudelytė, G; Navakauskienė, R; Virkšaitė, A | 1 |
| Chen, M; Gan, L; Li, L; Liu, B; Liu, L; Shan, Z; Xiao, C; Xu, T; Yao, S; Zhao, Y; Zhong, L | 1 |
| Erfanian, S; Moradzadeh, M; Roustazadeh, A; Sahebkar, A; Tabarraei, A | 1 |
| Baksiene, S; Borutinskaite, V; Navakauskiene, R; Vitkeviciene, A | 1 |
| Gao, HY; He, XW; Shi, X; Yan, W; Yang, W | 1 |
| Fatemi, A; Kazemi, A; Safa, M | 1 |
| Han, DH; Kim, JH | 1 |
| Annabi, B; Chokor, R; Vézina, A | 1 |
10 other study(ies) available for epigallocatechin gallate and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
(-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia.
Topics: Antineoplastic Agents; Calorimetry, Differential Scanning; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Nanomedicine; Nanoparticles; Particle Size | 2019 |
(-)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; Catechin; Cell Differentiation; Humans; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Mice, Transgenic; NIMA-Interacting Peptidylprolyl Isomerase; Reactive Oxygen Species; Retinoic Acid Receptor alpha; Spleen | 2021 |
Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells.
Topics: Acetylation; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers; Catechin; Cell Cycle Checkpoints; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Histones; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Polyphenols; Promoter Regions, Genetic; Tea | 2018 |
Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN.
Topics: Catechin; Cell Differentiation; Chromones; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Leupeptins; Morpholines; Phenanthrenes; Promyelocytic Leukemia Protein; Proteolysis; PTEN Phosphohydrolase; Retinoic Acid Receptor alpha; Tretinoin | 2017 |
Epigallocatechin-3-gallate enhances differentiation of acute promyelocytic leukemia cells via inhibition of PML-RARα and HDAC1.
Topics: Apoptosis; Catechin; Cell Differentiation; Cell Proliferation; Histone Deacetylase 1; Humans; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion | 2018 |
Epigallocatechin-3-gallate and BIX-01294 have different impact on epigenetics and senescence modulation in acute and chronic myeloid leukemia cells.
Topics: Antineoplastic Agents; Azepines; Catechin; Cellular Senescence; Chromobox Protein Homolog 5; Drug Screening Assays, Antitumor; Epigenesis, Genetic; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Quinazolines | 2018 |
[Effects of EGCG on Proliferation, Cell Cycle and DAPK1 Gene Methylation of Acute Promyelocytic Leukemia NB4 Cell Line].
Topics: Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Death-Associated Protein Kinases; Humans; Leukemia, Promyelocytic, Acute; Methylation | 2018 |
MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-κB pathway.
Topics: Apoptosis; Benzamides; Catechin; Cell Line, Tumor; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Promyelocytic, Acute; NF-kappa B; Phosphorylation; Signal Transduction; Telomerase | 2015 |
Difference in growth suppression and apoptosis induction of EGCG and EGC on human promyelocytic leukemia HL-60 cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Catechin; Cell Proliferation; Cricetinae; Dose-Response Relationship, Drug; Enzyme Activation; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Promyelocytic, Acute; Proto-Oncogene Proteins c-bcl-2; Time Factors | 2009 |
EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells.
Topics: Biomarkers, Tumor; Blood-Brain Barrier; Catechin; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; HL-60 Cells; Humans; I-kappa B Proteins; Leukemia, Promyelocytic, Acute; Macrophages; Matrix Metalloproteinase 9; Monocytes; NF-kappa B; Phosphorylation; Receptors, Laminin; Signal Transduction; Transcription, Genetic | 2012 |